Minimed Group, Inc. (MMED)
NASDAQ: MMED · Real-Time Price · USD
15.96
+0.20 (1.27%)
At close: Mar 16, 2026, 4:00 PM EDT
15.50
-0.46 (-2.88%)
After-hours: Mar 16, 2026, 7:56 PM EDT
Revenue
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
| FY 2025 | FY 2024 | FY 2023 |
|---|
| Apr '25 Apr 25, 2025 | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 |
|---|
| 541.00M | 540.00M | |
| 0.18% | 13.21% | |
| 854.00M | 777.00M | |
Consumables Revenue Growth | 9.91% | 2.24% | |
Continuous Glucose Monitoring (CGM) Revenue | 1.31B | 1.12B | |
Continuous Glucose Monitoring (CGM) Revenue Growth | 17.55% | 16.60% | |
| 6.00M | 34.00M | |
Other Segment Revenue Growth | -82.35% | -32.00% | |
Revenue by Geography
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
| FY 2025 | FY 2024 | FY 2023 |
|---|
| Apr '25 Apr 25, 2025 | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 |
|---|
| 903.00M | 833.00M | |
United States Revenue Growth | 8.40% | 0.12% | |
| 1.81B | 1.64B | |
International Revenue Growth | 10.76% | 15.78% | |
Key Performance Indicators
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
| FY 2025 | FY 2024 | FY 2023 |
|---|
| Apr '25 Apr 25, 2025 | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 |
|---|
US - Organic Revenue Growth | 8.40% | - | |
International - Organic Revenue Growth | 13.10% | 13.60% | |
Total Organic Revenue Growth | 11.50% | 8.60% | |
Updated undefined. Data Source:
Fiscal.ai.
